Skip to main content

Treatment of Acute Leukemia with L-Asparaginase — Preliminary Results on 84 Cases

  • Chapter
Experimental and Clinical Effects of L-Asparaginase

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 33))

Abstract

Between 1st of August 1968 and the 30th of April 1969 we treated 84 patients with L-asparaginase. This report deals with the results obtained.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson, R. M., Fabros: Antitumor activity and other biologic properties of L-asparaginase, a revue. Cancer Chemother. Rep. 52, 6 (1968).

    Google Scholar 

  2. Bernard, J., Boiron, M., Jacquillat, Cl., Najean, Y., Weil, M., Thomas, M.: Traitement des leucémies aigues lymphoblastiques de première atteinte par une association de Prednisone-Vincristine-Rubidomycine. Colloque International sur la Rubidomycine et la Daunomycine Paris Hôpital Saint-Louis 11, mars 1967. Path. et Biol. 15, 915–920 (1967).

    Google Scholar 

  3. Boiron, M., Jacquillat, Cl., Weil, M., Tanzer, J., Bernard, J.: L-asparaginase. Presse. méd. 76, 44, 2095–2101 (1968).

    Google Scholar 

  4. Broome, J. D.: Evidence that the L-asparaginase activity of Guinea Pig Serum is responsible for ills antilymphoma effects. Nature (Lond.) 191, 1114–1115 (1961).

    Article  CAS  Google Scholar 

  5. — Factors which may influence the effectiveness of L-asparaginase as Tumor inhibitors. Brit. J. Cancer XXII, 595 (1968).

    Article  Google Scholar 

  6. Burchenal, J. H., Oettgen, H. F.: Present states of L-asparaginase. Med. News (N. Y.), June 1968.

    Google Scholar 

  7. Canellos, G. P., Haskell, C. M., Arseneau, J., Carbone, P.: Hypoalbuminemic and hypocholesterolemic Effect of L-asparaginase (NSX-109229) Treatment on man: a preliminary report. Cancer Chemother. Rep. (in press).

    Google Scholar 

  8. Dolowy, Coll: Toxic and antineoplastic effects of L-asparaginase. Cancer Res. 19, 1813–1819 (1966).

    CAS  Google Scholar 

  9. Gralnick, H. R., Henry, P. H.: L-asparaginase induced coagulopathy. Proc. Amer. Ass. Cancer Res. 123, 32 (1969).

    Google Scholar 

  10. Grundmann, E.: L-asparaginase und Leukämie. Klin. Wschr. 2, 61–64 (1969).

    Article  Google Scholar 

  11. Harris, J. E., Whitecar, J. P., Bobey, G. P., Freireich, E. J.: L-asparaginase (ASP) in the treatment of adult acute leukemia. Proc. Amer. Ass. Cancer Res. 136, 35 (1969).

    Google Scholar 

  12. Haskell, C. M., Canellos, G. P.: Mechanisms of L-asparaginase resistance: asparagine synthetase in animal and human neoplasma. Proc. Amer. Ass. Cancer Res. 142, 36 (1969).

    Google Scholar 

  13. Leventhal, B. G., Carbone, P.: L-asparaginase toxicity. Cancer Res. 29, 974–975 (1969).

    PubMed  Google Scholar 

  14. Hill, J. M., Loeb, E., Roberts, J., MacLellan, A., Khan, A., Hill, N. O.: L-asparaginase therapy of Leukemia. Program of the XII Congress of the International Society of Hematology New York, (Abstract) 8 (1968).

    Google Scholar 

  15. Loeb, E., Roberts, J., MacLellan, A., Khan, A., Hill, N. O. — Robert, J., Loeb, E., Khan, A., MacLellan, A., Hill, R. W.: L-asparaginase therapy for leukemia and other malignant neoplasma. J. Amer. med. Ass. 202, 882–888 (1967).

    Article  CAS  Google Scholar 

  16. Ho, D. H., Frei, E.: Clinical Pharmacologic studies of L-asparaginase. Proc. Amer. Ass. Cancer Res. 151, 39 (1969).

    Google Scholar 

  17. Kidd, J. G.: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum: I. Course of transplanted cancers of various kinds on mice and rats given guinea pig serum, horse serum or rabbit serum. J. exp. Med. 98, 565–582 (1953).

    Article  PubMed  CAS  Google Scholar 

  18. Jacobs, S. P., Wodinsky, I., Kensler, C. J., Venditti, J., Little, A. D.: Therapy of experimental leukemias with combinations of L-asparagine and glutamine antagonists. Proc. Amer. Ass. Cancer Res. 168, 43 (1969).

    Google Scholar 

  19. Lash, E., Schwartz, M. K., Tallal, L., Oettgen, H. F.: Serum lipids in patients receiving L-asparaginase. Program of the XII congress of International Society of Hematology. New York (Abstract) 10, 1968.

    Google Scholar 

  20. Leventhal, B. G.: Asparaginase plus Azaserine in Acute lymphatic leukemia. Proc. Amer. Ass. Cancer Res. 193, 49 (1969).

    Google Scholar 

  21. Mashburn, L. T., Wriston, J. C., Jr.: Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch. Biochem. 105, 451–452 (1964).

    Article  Google Scholar 

  22. Mathé, G., Amiel, J. L., Schwartzenberg, L., Schneider, M., Cattan, A., Schlumberger, J. R., Hayart, M., de Vassai, F., Jasmin, C., Rosenfeld, C.: Essai de traitement de la leucémie aigue lymphoblastique par la L-asparaginase. Presse méd. 77, 461–463 (1968).

    Google Scholar 

  23. Oettgen, H. F.: Inhibition of leukemias in man by L-asparaginase. Cancer Res. 27, 2619–2631 (1967).

    PubMed  CAS  Google Scholar 

  24. — Plasma levels of L-asparaginase. Cancer Res. 27, 2630 (1967).

    Google Scholar 

  25. — Therapeutic effects of L-asparaginase on asparagine-dependent neoplasmas laboratory and clinical studies. J. Clin. Invest. 47, 74 a (1968).

    Google Scholar 

  26. Schulten, H. K.: Hemmuning maligner neoplasien des Menschen durch L-asparaginase. Klin. Wschr. 2, 65–71 (1969).

    Article  Google Scholar 

  27. Ohnuma, T., Holland, J. F., Freeman, A., Sinks, L.: Studies of asparaginase and asparagine in acute leukemia. Proc. Amer. Ass. Cancer Res. 262, 66 (1969).

    Google Scholar 

  28. Schmidt, C. G., Gallmeier, W. M.: Zur Enzymtherapie der Leukämien. Dtsch. med. Wschr. 48, 2299 (1968).

    Article  Google Scholar 

  29. Sobin, L. H., Kidd, J. G.: A metabolic difference between two lines of lymphoma 6C3HED cells in relation to asparagine. Proc. Soc. exp. Biol. (N. Y.) 119, 325–327 (1965).

    CAS  Google Scholar 

  30. Tallal, L., Tan, C., Oettgen, H. F., Mac Carty, M., Helson, L., Murphy, L.: L-asparaginase in 111 children with leukemias and solids tumors. Proc. Amer. Ass. Cancer Res. 394, 92 (1969).

    Google Scholar 

  31. Tan, C., Oettgen, H. F., Mac Carty, M., Helson, L., Murphy, L. —Oettgen, H. F.: Treatment of acute leukemia in children with L-asparaginase. Proc. Amer. Soc. Cancer Res. 9, 70 (1968).

    Google Scholar 

  32. Tan, C., Oettgen, H. F.: Clinical experience with L-asparaginase administrated intrathecally. Proc. Amer. Ass. Cancer Res. 365, 92 (1969).

    Google Scholar 

  33. Tarmowski, G. S., Mointain, I. M., Stock, C. C.: Combination therapy of animal tumors with L-asparaginase and glutamine antagonists. Proc. Amer. Ass. Cancer Res. 366, 92 (1969).

    Google Scholar 

  34. Tomas, R. A., Schwartz, M. K., Lash, E., Oettgen, H. F., Krakoff, I. H.: Blood Levels and distribution of L-asparaginase in man. Proc. Amer. Ass. Cancer Res. 371, 94 (1969).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1970 Springer-Verlag Berlin • Heidelberg

About this chapter

Cite this chapter

Jacquillat, C. et al. (1970). Treatment of Acute Leukemia with L-Asparaginase — Preliminary Results on 84 Cases. In: Grundmann, E., Oettgen, H.F. (eds) Experimental and Clinical Effects of L-Asparaginase. Recent Results in Cancer Research, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99984-0_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-99984-0_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-99986-4

  • Online ISBN: 978-3-642-99984-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics